A pilot program launched in 2013 for online drug retailing on third-party platforms in Hebei, Shanghai and Guangdong came to an end on August 1, the People's Daily Overseas Edition reported Monday, citing a notice by the China Food and Drug Administration (CFDA).As a result, drug sales on popular online shopping sites such as Tmall and Yhd.com have all been suspended, the paper said.
